Arginine: what it is and how it affects nitric oxide, blood pressure, and exercise

What arginine is

Arginine is an amino acid, one of the building blocks the body uses to assemble proteins following the instructions written in DNA. It’s classified as a semi-essential, or conditionally essential, amino acid: under normal conditions the body makes enough of it on its own, but at certain life stages or with particular health conditions the need can outstrip internal production, which is when diet starts to matter.

Unlike creatine, another well-studied nitrogen-containing compound in sports science, arginine doesn’t work on the muscle fibres’ energy system and isn’t among the known mechanisms behind muscle hypertrophy, the growth of tissue in response to training. Its best-studied role is different: it’s the starting molecule the body uses to produce nitric oxide.

How it works: the nitric oxide precursor

Inside the cells of the endothelium, the thin layer lining the inside of blood vessels, an enzyme called nitric oxide synthase uses arginine as raw material to produce nitric oxide. Nitric oxide is a messenger that acts locally, almost instantly: it tells the muscular wall of the blood vessel to relax, a process called endothelium-mediated vasodilation.

This mechanism underlies most of arginine’s studied uses: from blood pressure to athletic performance to erectile dysfunction, all phenomena where the widening of blood vessels plays a part. It’s also why arginine often shows up in products marketed as “vasodilators” or “pump” supplements in the fitness world.

Practical example: when blood flow to a tissue needs to increase quickly, during physical exertion for instance, the body doesn’t simply “open a tap”: it relaxes the vessels feeding that tissue. Nitric oxide produced from arginine is one of the chemical signals involved in that process.

How much arginine we already get from diet

Before even discussing supplements, it helps to know how much arginine already arrives through ordinary food. A population study of nearly 2,800 adults (average age 45.9) measured an average intake of about 4.4 g a day, with minimal differences between men and women. The main dietary sources in this sample were grains (about a third of total intake), meat (about 30%) and dairy (about 14%).

The same study found a significant association between higher dietary arginine intake and higher blood concentrations of nitric oxide metabolites, an association that was more pronounced in women, in older adults, and in people who were overweight or obese. This figure helps put the doses used in clinical trials into perspective, since they’re often far higher than a normal diet could ever supply.

Doses studied, field by field

The doses of arginine tested in studies vary widely depending on what’s being measured, and are almost always higher than the average dietary intake.

Field studied	Dose tested	Typical duration
Blood pressure	4-24 g/day (median 9 g/day)	2-24 weeks
Athletic performance, acute dose	0.075-0.15 g/kg body weight, or 2-6 g	30-270 minutes before exercise
Athletic performance, ongoing use	1.5-12 g/day	7-56 days
Erectile dysfunction	1,500-5,000 mg/day	Variable by study
Pressure injury wound healing	2.5-18 g/day	2-12 weeks

Notably, in the heart attack trial discussed further below, the dose was gradually raised to 3 g three times a day, or 9 g/day overall: a dose still in the high range compared with the other fields, given to a population of fragile patients recovering from an acute cardiac event.

Blood pressure: what the meta-analyses show

The reference meta-analysis on arginine and blood pressure pooled 11 randomized, double-blind, placebo-controlled trials, totalling 387 participants aged 12 to 79. The result: an average reduction in systolic pressure of 5.39 mmHg and in diastolic pressure of 2.66 mmHg versus placebo, both statistically significant. The same authors conclude that oral arginine supplementation “significantly lowers both systolic and diastolic blood pressure.”

Whoever reviewed this meta-analysis independently, though, added an important note of caution: limitations in the evidence base and a lack of precision in the estimates suggest the conclusions should be considered tentative rather than definitive. It’s a useful reminder whenever a single positive nutrition result makes headlines: the direction of an effect can be real while its exact size stays uncertain until larger, more consistent studies arrive.

Athletic performance: small but measurable effects

A systematic review and meta-analysis published in Nutrients in 2020 examined 15 studies (394 total participants, 282 of them trained or elite athletes) to see what happens to physical performance with arginine supplementation.

On anaerobic performance, tests shorter than 5 minutes, the meta-analysis finds a small but statistically significant effect, with minimal variability across the included studies. On aerobic performance, longer tests up to maximum oxygen consumption, the average effect is larger, but with very high heterogeneity across studies, a sign that results aren’t consistent from one study to the next and so should be read with caution.

For acute protocols, the same authors point to doses around 0.15 g/kg body weight taken 60 to 90 minutes before exertion (about 10-11 g for a 70 kg person), while for ongoing protocols they point to a range between 1.5 and 2 g a day for at least 4-7 doses, or 10-12 g a day for 8 weeks.

Erectile dysfunction: two positions, not one certainty

On arginine and erectile dysfunction, two different readings exist, and it’s important not to flatten them into a single answer.

On one hand, a 2019 meta-analysis of 10 randomized trials and 540 patients with erectile dysfunction finds an odds ratio of 3.37 favouring arginine over placebo, with significant improvements in several sub-scores tied to satisfaction and erectile function (the sexual desire score, by contrast, didn’t change meaningfully). Reported side effects were more frequent in the arginine group (8.3% versus 2.3% for placebo) but none were severe. The authors’ conclusion is nonetheless narrow: arginine can be considered for mild or moderate erectile dysfunction, not as a substitute for prescribed therapy in more severe cases. A separate review of a combination of arginine aspartate and Pycnogenol, a plant extract, found even larger improvements, but that’s a combination of two different substances, not direct evidence of arginine’s effect on its own.

On the other hand, the EFSA Panel assessed the specific claim “arginine helps to induce and improve erection” in 2011 and rejected it, concluding that the available intervention studies didn’t show a cause-and-effect relationship strong enough to authorise it. The two assessments don’t so much contradict each other as answer different questions: the scientific meta-analysis registers a positive signal in the available literature, while EFSA applies the stricter standard required to authorise a claim on a product label, and by that standard the data fell short.

Wound healing in pressure injuries

A field less known to the public but still studied is pressure injuries, skin lesions that form mostly in bedridden patients or those with reduced mobility. A meta-analysis of 8 studies and 196 total patients, conducted in several countries between 2001 and 2017, finds significant improvement in wound healing with arginine supplementation, with a clearly dose-dependent effect: at doses of at least 15 g a day the effect was much larger than at lower doses. No adverse side effects were reported in the data analysed by this review, though this is a specific clinical setting, with patients monitored by healthcare staff, not comparable to the unsupervised use of an over-the-counter supplement.

Safety: the serious contraindication after a heart attack

The most important safety finding on arginine concerns one specific population: people with a recent heart attack. A randomized, double-blind, placebo-controlled trial (VINTAGE MI, published in JAMA in 2006) enrolled 153 patients with a first ST-elevation heart attack, assigning them to arginine or placebo about six days after admission. The arginine dose was gradually increased to 3 g three times a day (9 g/day overall), maintained for 6 months.

The result led to the trial’s early termination: 8.6% of patients in the arginine group died within 6 months, versus no deaths in the placebo group, a statistically significant difference. Most of the deaths occurred in patients aged 60 or older. Even on a broader composite outcome (death, a new heart attack, or hospitalisation for heart failure), the result was worse with arginine, 16.7% versus 10.1%, with arginine showing no measurable benefit on vascular stiffness or left ventricular function. The trial’s independent safety monitoring board recommended stopping it ahead of schedule, and the authors were blunt in their conclusion: arginine should not be given to patients after a heart attack.

The same researchers discuss a hypothesis for the excess mortality: in older patients with widespread atherosclerosis, the physiological response to arginine might be different, and unfavourable, compared with what’s seen in younger or healthier people. It holds as a general principle: an effect measured in one population (healthy adults, say, in the other studies discussed further up) doesn’t automatically carry over to a different population with different health conditions, especially in the cardiovascular field.

Other risks: high doses, kidneys, liver, herpes

Aside from the specific contraindication after a heart attack, the literature describes arginine as generally safe, with side effects that are rare and dose-related. According to a review of the gastrointestinal safety of amino acids, single doses up to 3-6 g rarely cause problems, while the risk of issues such as bloating, nausea, diarrhoea and abdominal cramps rises mainly with single doses above 9 g, often within daily regimens that are very high overall, above 30 g a day. The proposed mechanism is straightforward: amino acids that are only partly absorbed draw water into the intestine by osmosis, causing diarrhoea. Splitting the daily dose into several servings and taking it with food appears to reduce this risk.

Two other situations call for caution. People with kidney or liver failure may not be able to properly metabolise and excrete supplemental arginine, and so should be monitored. People with herpes infections should be cautious because the herpes simplex virus needs arginine itself to replicate, while another amino acid, lysine, has an antagonistic effect: preliminary data suggest arginine supplementation might not be advisable in the presence of this infection.

Finally, it’s worth remembering that all these mechanisms, from protein synthesis to enzyme activity, take place inside the body’s cells: understanding how a cell works helps explain why an amino acid like arginine can have such different effects depending on the tissue and the health condition of the person taking it.